Acquired immune tolerance 2.0

IF 8.2 2区 医学 Q1 SURGERY American Journal of Transplantation Pub Date : 2025-05-01 Epub Date: 2025-03-07 DOI:10.1016/j.ajt.2025.02.020
Qizhi Tang
{"title":"Acquired immune tolerance 2.0","authors":"Qizhi Tang","doi":"10.1016/j.ajt.2025.02.020","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":123,"journal":{"name":"American Journal of Transplantation","volume":"25 5","pages":"Pages 890-892"},"PeriodicalIF":8.2000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Transplantation","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1600613525001030","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/7 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
获得性免疫耐受2.0。
肝移植后,一些患者自发地对移植物产生耐受,可以在保持功能、生化和组织学完整性的同时停止免疫抑制。自发肝移植耐受率从13%到80%不等,取决于移植后的时间和免疫抑制停药的资格标准(1)。最近结束的两项肝移植免疫抑制停药试验LIFT和OPTIMAL发现,在经过广泛筛选和选择的接受医学监督的免疫抑制停药的患者中,自发肝移植耐受率几乎相同,为16%(1)。2).确定耐受性的前瞻性生物标志物将有助于选择免疫抑制停药的耐受性患者,并可能为指导新耐受性方案的设计提供潜在的免疫学机制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
18.70
自引率
4.50%
发文量
346
审稿时长
26 days
期刊介绍: The American Journal of Transplantation is a leading journal in the field of transplantation. It serves as a forum for debate and reassessment, an agent of change, and a major platform for promoting understanding, improving results, and advancing science. Published monthly, it provides an essential resource for researchers and clinicians worldwide. The journal publishes original articles, case reports, invited reviews, letters to the editor, critical reviews, news features, consensus documents, and guidelines over 12 issues a year. It covers all major subject areas in transplantation, including thoracic (heart, lung), abdominal (kidney, liver, pancreas, islets), tissue and stem cell transplantation, organ and tissue donation and preservation, tissue injury, repair, inflammation, and aging, histocompatibility, drugs and pharmacology, graft survival, and prevention of graft dysfunction and failure. It also explores ethical and social issues in the field.
期刊最新文献
Racial and Immunologic Disparities Impact Access to Kidney Re-Waitlisting and Retransplantation Selective Impact on Regulatory T cell with Sustained Functional Phenotype by the IL-2 Mutein VIS171 in a Nonhuman Primate Model Preclinical and Clinical Studies on Kidney Allograft Tolerance via Hematopoietic Chimerism. Determining the Critical Graft-to-recipient Weight Ratio Threshold for Safety in Full-right/Full-left Split Liver Transplantation: A Multicentric Cohort Study. Donor-reactive clonotypes are overrepresented in the urinary T-cell repertoire during kidney transplant rejection and show distinct dynamics in the circulation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1